Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dengue | 12 | 2023 | 100 | 3.070 |
Why?
|
| Macaca mulatta | 20 | 2023 | 139 | 2.660 |
Why?
|
| Dengue Virus | 11 | 2023 | 89 | 2.060 |
Why?
|
| Antibodies, Viral | 13 | 2024 | 295 | 1.610 |
Why?
|
| Antibodies, Neutralizing | 10 | 2024 | 118 | 1.590 |
Why?
|
| Immunity, Humoral | 2 | 2021 | 26 | 1.370 |
Why?
|
| Antibody-Dependent Enhancement | 2 | 2017 | 3 | 1.100 |
Why?
|
| Immunity, Cellular | 2 | 2020 | 73 | 0.800 |
Why?
|
| Immunoglobulin G | 1 | 2024 | 253 | 0.770 |
Why?
|
| Immunity, Innate | 4 | 2020 | 168 | 0.760 |
Why?
|
| Interferons | 2 | 2013 | 37 | 0.680 |
Why?
|
| T-Lymphocytes | 3 | 2020 | 378 | 0.670 |
Why?
|
| Genes, MHC Class I | 1 | 2018 | 14 | 0.580 |
Why?
|
| Genes, MHC Class II | 1 | 2018 | 20 | 0.580 |
Why?
|
| Flaviviridae Infections | 1 | 2017 | 1 | 0.560 |
Why?
|
| Dengue Vaccines | 4 | 2021 | 15 | 0.560 |
Why?
|
| Gene Frequency | 1 | 2018 | 203 | 0.560 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 203 | 0.550 |
Why?
|
| Flavivirus | 1 | 2017 | 16 | 0.540 |
Why?
|
| Puerto Rico | 6 | 2021 | 1376 | 0.530 |
Why?
|
| Cytokines | 6 | 2019 | 661 | 0.530 |
Why?
|
| Vaccination | 4 | 2024 | 332 | 0.500 |
Why?
|
| Animals | 22 | 2023 | 16695 | 0.460 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 5 | 2019 | 57 | 0.460 |
Why?
|
| Serine Endopeptidases | 2 | 2019 | 48 | 0.450 |
Why?
|
| Viral Nonstructural Proteins | 2 | 2019 | 51 | 0.440 |
Why?
|
| Immune Evasion | 1 | 2013 | 17 | 0.420 |
Why?
|
| Viral Envelope Proteins | 6 | 2023 | 90 | 0.410 |
Why?
|
| I-kappa B Kinase | 1 | 2013 | 50 | 0.400 |
Why?
|
| Simian immunodeficiency virus | 5 | 2019 | 61 | 0.400 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2011 | 5 | 0.360 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2011 | 4 | 0.360 |
Why?
|
| Cross Reactions | 4 | 2021 | 86 | 0.350 |
Why?
|
| Breeding | 2 | 2016 | 28 | 0.350 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2011 | 11 | 0.350 |
Why?
|
| Male | 14 | 2023 | 22779 | 0.330 |
Why?
|
| Specific Pathogen-Free Organisms | 3 | 2018 | 23 | 0.330 |
Why?
|
| Meningoencephalitis | 1 | 2009 | 14 | 0.320 |
Why?
|
| Mycobacterium Infections | 1 | 2009 | 16 | 0.310 |
Why?
|
| Virus Replication | 1 | 2011 | 318 | 0.290 |
Why?
|
| Humans | 19 | 2024 | 42163 | 0.280 |
Why?
|
| Microsatellite Repeats | 2 | 2017 | 60 | 0.260 |
Why?
|
| Cervix Uteri | 2 | 2019 | 47 | 0.260 |
Why?
|
| Vagina | 2 | 2019 | 89 | 0.260 |
Why?
|
| Immunity | 2 | 2019 | 60 | 0.260 |
Why?
|
| Dendritic Cells | 2 | 2020 | 130 | 0.260 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 173 | 0.250 |
Why?
|
| Time Factors | 3 | 2020 | 1848 | 0.250 |
Why?
|
| Genetics, Population | 2 | 2017 | 118 | 0.250 |
Why?
|
| Herpesvirus 1, Cercopithecine | 1 | 2005 | 2 | 0.230 |
Why?
|
| Monkey Diseases | 1 | 2005 | 6 | 0.230 |
Why?
|
| Herpesviridae Infections | 1 | 2005 | 18 | 0.230 |
Why?
|
| Social Alienation | 1 | 2023 | 4 | 0.210 |
Why?
|
| Genetic Variation | 2 | 2017 | 429 | 0.210 |
Why?
|
| HLA-DR Antigens | 1 | 2023 | 23 | 0.210 |
Why?
|
| Neutralization Tests | 2 | 2021 | 55 | 0.210 |
Why?
|
| Viremia | 3 | 2019 | 44 | 0.210 |
Why?
|
| AIDS Vaccines | 3 | 2007 | 25 | 0.190 |
Why?
|
| Cross Protection | 1 | 2021 | 5 | 0.180 |
Why?
|
| Female | 9 | 2023 | 24018 | 0.180 |
Why?
|
| Mucous Membrane | 2 | 2019 | 34 | 0.170 |
Why?
|
| K562 Cells | 2 | 2017 | 32 | 0.160 |
Why?
|
| Immunologic Factors | 1 | 2020 | 50 | 0.160 |
Why?
|
| Semen | 1 | 2019 | 55 | 0.150 |
Why?
|
| RNA, Messenger | 1 | 2024 | 1265 | 0.150 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 1051 | 0.150 |
Why?
|
| Animals, Laboratory | 1 | 2018 | 3 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2019 | 276 | 0.140 |
Why?
|
| Primate Diseases | 1 | 2017 | 4 | 0.140 |
Why?
|
| Mutation | 2 | 2021 | 1169 | 0.140 |
Why?
|
| Protein Binding | 1 | 2021 | 1076 | 0.140 |
Why?
|
| Vaccines, DNA | 3 | 2007 | 24 | 0.140 |
Why?
|
| Haplotypes | 1 | 2018 | 197 | 0.140 |
Why?
|
| Animal Population Groups | 1 | 2017 | 1 | 0.140 |
Why?
|
| Immune Sera | 1 | 2017 | 56 | 0.140 |
Why?
|
| Animals, Wild | 1 | 2017 | 24 | 0.130 |
Why?
|
| Pedigree | 1 | 2017 | 94 | 0.130 |
Why?
|
| Alleles | 1 | 2018 | 352 | 0.130 |
Why?
|
| Cell Line | 2 | 2019 | 1416 | 0.130 |
Why?
|
| Models, Animal | 1 | 2017 | 149 | 0.130 |
Why?
|
| Genetic Drift | 1 | 2016 | 5 | 0.120 |
Why?
|
| Caribbean Region | 1 | 2016 | 75 | 0.120 |
Why?
|
| Serologic Tests | 2 | 2022 | 45 | 0.100 |
Why?
|
| Endometrium | 1 | 2014 | 60 | 0.100 |
Why?
|
| Protein Interaction Mapping | 1 | 2013 | 64 | 0.100 |
Why?
|
| Encephalitis Virus, Venezuelan Equine | 1 | 2013 | 11 | 0.100 |
Why?
|
| Inflammation | 2 | 2023 | 729 | 0.100 |
Why?
|
| Flow Cytometry | 2 | 2011 | 411 | 0.090 |
Why?
|
| Serotyping | 2 | 2014 | 37 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2011 | 246 | 0.090 |
Why?
|
| Adult | 3 | 2021 | 13458 | 0.090 |
Why?
|
| HIV-1 | 3 | 2007 | 747 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2013 | 1617 | 0.090 |
Why?
|
| Drug Carriers | 1 | 2013 | 169 | 0.090 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2010 | 15 | 0.080 |
Why?
|
| Interleukin-18 | 1 | 2010 | 16 | 0.080 |
Why?
|
| Interleukin-12 | 1 | 2010 | 46 | 0.080 |
Why?
|
| Morphine Dependence | 1 | 2010 | 23 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2007 | 456 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2009 | 46 | 0.080 |
Why?
|
| Granuloma | 1 | 2009 | 24 | 0.080 |
Why?
|
| Aged | 1 | 2021 | 7982 | 0.070 |
Why?
|
| Middle Aged | 2 | 2021 | 11819 | 0.070 |
Why?
|
| Genetics | 1 | 2007 | 10 | 0.070 |
Why?
|
| Epidemiology | 1 | 2007 | 9 | 0.070 |
Why?
|
| Vaccines, Attenuated | 2 | 2019 | 75 | 0.070 |
Why?
|
| Digestive System | 1 | 2007 | 21 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2007 | 73 | 0.070 |
Why?
|
| Marburgvirus | 1 | 2006 | 8 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2007 | 190 | 0.060 |
Why?
|
| Vaccinia virus | 1 | 2006 | 12 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2023 | 181 | 0.060 |
Why?
|
| Ebolavirus | 1 | 2006 | 48 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 310 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2006 | 127 | 0.060 |
Why?
|
| Animal Husbandry | 1 | 2005 | 19 | 0.060 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2005 | 106 | 0.060 |
Why?
|
| Proteins | 1 | 2007 | 383 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 599 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 683 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 602 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2021 | 19 | 0.050 |
Why?
|
| Algorithms | 1 | 2005 | 508 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 1066 | 0.050 |
Why?
|
| Antigens, Viral | 1 | 2021 | 50 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2005 | 1020 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 1554 | 0.040 |
Why?
|
| RNA Helicases | 1 | 2019 | 19 | 0.040 |
Why?
|
| Receptors, CCR5 | 1 | 2019 | 64 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 658 | 0.040 |
Why?
|
| Mice | 2 | 2021 | 6490 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2019 | 75 | 0.040 |
Why?
|
| HIV Infections | 2 | 2019 | 2535 | 0.040 |
Why?
|
| Genotype | 1 | 2021 | 796 | 0.040 |
Why?
|
| Virulence | 1 | 2019 | 238 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2014 | 1188 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 1804 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2015 | 35 | 0.030 |
Why?
|
| Thailand | 1 | 2015 | 51 | 0.030 |
Why?
|
| Singapore | 1 | 2015 | 32 | 0.030 |
Why?
|
| Colombia | 1 | 2015 | 30 | 0.030 |
Why?
|
| Safety | 1 | 2015 | 51 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2015 | 305 | 0.030 |
Why?
|
| Plasma | 1 | 2014 | 38 | 0.030 |
Why?
|
| United States | 1 | 2005 | 5072 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2014 | 200 | 0.030 |
Why?
|
| Species Specificity | 1 | 2014 | 279 | 0.020 |
Why?
|
| Macaca | 1 | 2013 | 36 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2014 | 114 | 0.020 |
Why?
|
| Vaccines, Synthetic | 1 | 2013 | 78 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 427 | 0.020 |
Why?
|
| Viral Load | 1 | 2014 | 344 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2013 | 165 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 522 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 491 | 0.020 |
Why?
|
| Infant | 1 | 2015 | 1143 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2015 | 1516 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1559 | 0.020 |
Why?
|
| Genes | 1 | 2007 | 56 | 0.020 |
Why?
|
| Fusion Proteins, gag-pol | 1 | 2007 | 2 | 0.020 |
Why?
|
| HIV Core Protein p24 | 1 | 2007 | 11 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2007 | 37 | 0.020 |
Why?
|
| Child | 1 | 2015 | 3381 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 2007 | 19 | 0.020 |
Why?
|
| Rectum | 1 | 2007 | 27 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2007 | 198 | 0.020 |
Why?
|
| Molecular Biology | 1 | 2007 | 47 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2007 | 105 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2006 | 25 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2007 | 124 | 0.020 |
Why?
|
| Administration, Rectal | 1 | 2006 | 18 | 0.020 |
Why?
|
| Africa, Western | 1 | 2005 | 19 | 0.020 |
Why?
|
| Gene Products, gag | 1 | 2005 | 11 | 0.020 |
Why?
|
| Gene Products, env | 1 | 2005 | 23 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 649 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2005 | 75 | 0.010 |
Why?
|
| Epitopes | 1 | 2005 | 155 | 0.010 |
Why?
|
| Monocytes | 1 | 2007 | 275 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 4936 | 0.010 |
Why?
|
| Plasmids | 1 | 2005 | 247 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 5950 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 526 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 363 | 0.010 |
Why?
|
| Apoptosis | 1 | 2006 | 1541 | 0.010 |
Why?
|